Document Detail


Embryonic development and pregnancy test sensitivity: the importance of earlier pregnancy detection.
MedLine Citation:
PMID:  19863469     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Embryogenesis research provides information on a time of heightened vulnerability in embryo development: the time from conception to the day a woman misses her menstrual period. During this period, it is vital for the woman to be aware of exposures, behaviors and nutritional factors that could negatively impact the developing embryo. This article discusses this critical, often-overlooked window of development and will review the various types of teratogens that affect pregnancy. Over-the-counter pregnancy tests are widely used to determine pregnancy status. Earlier test models detected only the pregnancy hormone human chorionic gonadotropin in the urine, but it is now known that there are other key forms of human chorionic gonadotropin that are relevant when determining pregnancy status. This article will explain why early knowledge of pregnancy status is important for both woman and embryo, and the role that patient education and pregnancy test choice can have on normal embryonic development.
Authors:
Mary Jane Minkin
Related Documents :
15792629 - Metabolic changes in japanese medaka (oryzias latipes) during embryogenesis and hypoxia...
17207339 - High rate of biological loss in assisted reproduction: it is in the seed, not in the soil.
11495409 - Successful day 5 embryo transfer and pregnancies resulting after transport of embryos b...
14720589 - Developmental regulation of catecholamine levels during sea urchin embryo morphogenesis.
16727449 - Splitting of porcine embryos at the four-cell or morula stage.
3680489 - Cryopreservation of human embryos obtained after gamete intra-fallopian transfer and/or...
2737359 - Components of change in adolescent fertility, 1971-1979.
15622129 - The contribution of cervical propriospinal premotoneurons in recovering hemiparetic str...
16175029 - Severe cardiac disease in pregnancy, part i: hemodynamic changes and complaints during ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Women's health (London, England)     Volume:  5     ISSN:  1745-5065     ISO Abbreviation:  -     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-10-29     Completed Date:  2010-01-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101271249     Medline TA:  Womens Health (Lond Engl)     Country:  England    
Other Details:
Languages:  eng     Pagination:  659-67     Citation Subset:  IM    
Affiliation:
Yale University School of Medicine, 40 Temple Street, Suite 7A, New Haven, CT 06510, USA. maryjane.minkin@yale.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chronic Disease
Counseling
Embryonic Development / drug effects*
Female
Humans
Maternal Exposure / prevention & control
Patient Education as Topic
Pharmaceutical Preparations / adverse effects
Pregnancy
Pregnancy Complications / prevention & control
Pregnancy Tests*
Prenatal Exposure Delayed Effects
Sensitivity and Specificity
Substance-Related Disorders
Teratogens / toxicity
Time Factors
Chemical
Reg. No./Substance:
0/Pharmaceutical Preparations; 0/Teratogens

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Can pregnant diabetics be treated with glyburide?
Next Document:  Women and peripheral arterial disease.